AAM Founders Series | Association for Accessible Medicines

AAM All Access Podcast - AAM CEO Dan Leonard convenes industry and policy experts to explore why the Inflation Reduction Act (f/k/a Build Back Better) reduces generic and biosimilar competition.

Learn More

We’re profiling the founders of the industry, view below to read all of their stories. 

Listen to Their Stories

Preview of The New York Times article: William Haddad, Crusader for Generic Drugs, Dies at 91

Blog

May 13, 2020 | Bob Billings

Thank You, Bill Haddad

The New York Times article: Agnes Varis, Founder of Drug Company, Dies at 81

Blog

Jun 16, 2020 | Bob Billings

Thank you, Agnes Varis

Lupin Pharmaceutical and Chairman Desh Bandhu Gupta

Blog

Jun 26, 2020 | Bob Billings

Thank you, Desh Bandhu Gupta

Carole Ben-Maimon—President and CEO of Larimar Therapeutics

Blog

Jul 30, 2020 | Bob Billings

Thank you, Carole Ben-Maimon

Henry Waxman, Chairman, Waxman Strategies

Blog

Sep 24, 2020 | Bob Billings

Thank you, Rep. Henry Waxman

Blog

Oct 23, 2020 | Bob Billings

Thank you, Mike Puskar

Blog

Jan 4, 2021 | Bob Billings

Thank you, Jean Hoffman

Eli Hurvitz (1932–2011) | Photo by Moshe Shai

Blog

Jul 1, 2021 | Bob Billings

Thank you, Eli Hurvitz

Blog

Sep 21, 2021 | Bob Billings

Thank you, Kanu Patel

Blog

Dec 14, 2021 | Bob Billings

Thank you, Ramprasad Reddy